admin
India
healthysoch
Gurugram/Chandigarh, March 30, 2020:
Three COVID-19 patient has been discharged from Fortis Memorial Research Institute (FMRI), Gurugram. The patients have fully recovered.
While two patients were discharged on 29th March, one patient has been discharged today. Two of the patients released from FMRI were siblings who had a travel history to the UK. Both were admitted with complaints of fever and cough on 21st of March 2020. They were treated in an isolation ward and responded well to the treatment. Their test results for COVID19 are negative for two days and their chest X-ray reports are normal. They have been discharged with home care advice.
While the third patient is a 29- year old male with a travel history to UK. He returned from UK on 18th March and had symptoms of fever, cough and cold. He was found to be positive of Coronavirus and was admitted to FMRI on 22nd March. He was treated as per the symptoms. The patient responded well to treatment and his chest x-ray was normal. Repeat tests for Coronavirus twice in the interval of 24 hours came to be negative. Patient is discharged from the hospital today.
Dr Manoj Goel, Director and Head, Pulmonology, Critical Care and Sleep Medicine, Fortis Memorial Research Institute (FMRI) said, “At the moment, the therapeutic strategies to deal with COVID19 infection are only supportive, and prevention aimed at reducing transmission in the community is our best weapon. The treatment essentially is symptomatic in the majority of the patients and aimed at relieving fever, cough and shortness of breath. In mild cases, this might simply mean rest and fever-reducing medications such as paracetamol for comfort.
Oxygen therapy represents the major treatment intervention for patients with severe infection. Mechanical ventilation may be necessary in cases of respiratory failure refractory to oxygen therapy. Support for other failing organs such as dialysis may also be required. There is no specific antiviral treatment for COVID-19, and no vaccine is currently available. However, in severe cases, a few drugs have been found to be useful in reducing the viral load, leading to improved outcomes”.
Speaking on the preparedness of Fortis to treat COVID19 patients, Dr Ritu Garg, Facility Director, Fortis Memorial Research Institute (FMRI) said, “We are pleased to share that the three patients admitted at FMRI and undergoing treatment for COVID19 have been discharged. We are working closely with the local authorities and the healthcare delivery system to effectively combat this pandemic. A “3-tier COVID defence structure” is in place at all Fortis hospitals, with screening, Fever (FLU) Clinics, and in-patient isolation facilities. We are continuously monitoring the situation and will do everything possible to expand bed availability as required. We have also implemented necessary safety protocols to keep our doctors, nurses, other patients, visitors and staff safe.”
Fortis Healthcare, India’s leading healthcare solution provider, has initiated a 360-degree action plan to meet the challenges of treating COVID19 patients with a slew of initiatives. It has set up isolation wards in all its 28 hospitals across the country and a total of 262 beds have been earmarked to treat COVID19 patients. The medical teams at Fortis group are already treating 27 COVID19 positive cases along with 87 suspected cases at various hospitals.
healthysoch
